Addenbrooke's doctor and University of Cambridge professor Ravindra Gupta has won the prestigious Translational Microbiology Prize as well as being named as one of the world's most influential researchers of 2022.
The prize is awarded by the Microbiology Society and recognises his significant contribution to research. In the same month, Ravi has been named as one of the world’s most influential researchers in the 2022 list of Highly Cited Researchers.
The list is published by global insight provider Clarivate and is a major accolade in the field of research.
Drawing on his extensive work on HIV drug resistance, Professor Gupta and his team have played a vital role in the fight against COVID-19. During the pandemic they introduced SAMBA II testing at Addenbrooke’s which enabled faster diagnosis in order to provide the safest possible care to patients.
The team has also worked to understand how new variants of the virus arise and how they are transmitted.
I am thrilled and honoured to receive the Translational Microbiology Prize. For me, it represents a recognition of the work of my team and our collaborators over the years in applying scientific knowledge to combat viruses such as HIV-1 and SARS-CoV-2. This award from an internationally reputed organisation in infectious diseases also provides impetus to continue our endeavours with ever greater passion and commitment.Professor Ravindra Gupta
In 2020 Ravi was named as one of the 100 Most influential people by TIME.
In addition to his roles at Addenbrooke’s, he is a professor at the University of Cambridge, Professor of Clinical Microbiology at the Cambridge Institute for Therapeutic Immunology, holds a faculty position at the Africa Health Research Institute (AHRI) and was elected to Fellowship of the Academy of Medical Sciences UK in 2021.